Nippon Chemiphar CoTSE:4539 +1.38%59 Net Margin % is 0.20% as of Mar. 2026, which is 86% below its 10-year median of 1.47. GuruFocus rates TSE:4539 with a GF Score™ of 59/100 and a GF Value™ of 円1,705.64 (Fairly Valued). The stock has 9 warning signs investors should review. Among 962 Drug Manufacturers companies, Nippon Chemiphar Co ranks worse than 64.97% on this metric.
The historical rank and industry rank for Nippon Chemiphar Co's Net Margin % or its related term are showing as below:
TSE:4539'
s Net Margin % Range Over the Past 10 Years
Min: -0.59 Med: 1.47 Max: 5.76
Current: 0.6
TSE:4539's Net Margin % is ranked worse than 64.97% of 962
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs TSE:4539: 0.60
Nippon Chemiphar Co (TSE:4539) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Nippon Chemiphar Co Net Margin % Related Terms
Nippon Chemiphar Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Nippon Chemiphar Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Chemiphar Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nippon Chemiphar Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nippon Chemiphar Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Nippon Chemiphar Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nippon Chemiphar Co (TSE:4539) has a Net Margin % of 0.20% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Nippon Chemiphar Co and its competitors. This is 86% below median its historical median of 1.47. According to the industry distribution chart, Nippon Chemiphar Co ranks #625 out of 962 companies in the Drug Manufacturers industry, placing it in the top 65%.
Is Nippon Chemiphar Co's Net Margin % too high?
Nippon Chemiphar Co's current Net Margin % of 0.20% is 86% below median its 10-year median of 1.47. The Drug Manufacturers industry median Net Margin % is 5.56. Nippon Chemiphar Co's value of 0.20% is 96.4% below this industry median. Based on the distribution chart, Nippon Chemiphar Co ranks #625 out of 962 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Nippon Chemiphar Co has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nippon Chemiphar Co's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Nippon Chemiphar Co ranks #625 out of 962 companies for Net Margin %. This places Nippon Chemiphar Co in the lower half of its industry. The industry median Net Margin % is 5.56. Nippon Chemiphar Co's value of 0.20% is 96.4% below this benchmark. While the company's 10-year median is 1.47 vs. the industry median of 5.56, Nippon Chemiphar Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nippon Chemiphar Co's current Net Margin % of 0.20% is 96.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Nippon Chemiphar Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nippon Chemiphar Co's current Net Margin % is 0.20%, which is 86% below median its own 10-year median of 1.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nippon Chemiphar Co stock overvalued right now?
Based on GuruFocus' analysis, Nippon Chemiphar Co (TSE:4539) is currently considered Fairly Valued. The stock's GF Value™ is 円1,705.64, compared to a current price of 円1,692.00 — trading 0.8% below its estimated fair value. The current Net Margin % is 0.20%, which is 86% below median its 10-year median of 1.47 and 96.4% below the Drug Manufacturers industry median of 5.56. Nippon Chemiphar Co's overall GF Score™ is 59/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Nippon Chemiphar Co (TSE:4539), the current Net Margin % is 0.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nippon Chemiphar Co (TSE:4539) Overvalued in 2026?
Based on GuruFocus' analysis, Nippon Chemiphar Co stock appears to be undervalued.
The current stock price of 円1,692.00 is trading 0.8% below its estimated GF Value™ of 円1,705.64.
GuruFocus considers Nippon Chemiphar Co to be Fairly Valued.
Key valuation signals for TSE:4539:
Net Margin %: 0.20% (86% below median its 10-year median of 1.47)
GF Value™: 円1,705.64 vs. price of 円1,692.00 (0.8% below fair value)
Industry Position: 96.4% below the Drug Manufacturers median (#625 of 962)
No single metric tells the full story. See the TSE:4539 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nippon Chemiphar Co Ltd produces and sells medicines for medical use. The company also produces medical, health and cosmetics products. Nippon Chemiphar sterilizes medical instruments for hospitals and operates nursing home for elderly.
59GF Score
Get the complete analysis for TSE:4539
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4539 has been successfully added to your 
